The French company Sanofi and Britain's GlaxoSmithKline have started a clinical trial to test a vaccine for the Corona virus.
According to Arabiyanet, the two companies said, in a joint statement, that they have started the first phase of a two-stage test of the vaccine that they hope to roll out worldwide.
The vaccine uses technology Sanofi uses to produce the seasonal influenza vaccine and GlaxoSmithKline technology.
Pharmaceutical companies and governments are working around the world to develop treatments for the Covid-19 pandemic that has killed more than 861,000 people and disrupted economic activity.
Sanofi and Glaxo said that they expect the first results of the vaccine by December 2020, and if the results are positive, they will plan to seek approval of the relevant authorities for the vaccine in the first half of 2021.
>
According to the World Health Organization data, there are 175 vaccines for Coronavirus currently being developed around the world, while 33 vaccines have reached the stage of clinical trials.
(Amazon fun knowledge)
